There are marked variations in the activity of lipoprotein lipase (LPL) among adipose depots, particularly in women. Consistent with data on LPL activity, the level of expression of LPL mRNA was lower in omental (OM) than subcutaneous (SQ) adipose tissue of women. To investigate the cellular basis of these differences, OM and SQ adipose tissues obtained at surgery from obese men and women were placed in organ culture for 7 d with varying concentrations of insulin and dexamethasone. Insulin increased levels of LPL mRNA and LPL activity in abdominal SQ but not OM adipose tissue. Dexamethasone also increased LPL mRNA and LPL activity, and these effects were more marked in the OM adipose tissue, particularly in men. When insulin and dexamethasone were added together, synergistic increases in LPL activity were seen in both depots, and this was in part explained at the level of LPL mRNA. The SQ depot was more sensitive to the effects of submaximal doses of dexamethasone in the presence of insulin. The maximum activity of LPL induced by insulin or insulin plus dexamethasone was higher in the SQ than in the OM depot of women, and this was associated with higher levels of LPL mRNA. Rates of LPL synthesis paralleled LPL mRNA levels. These data show that insulin and glucocorticoids influence human adipose tissue LPL activity at the level of LPL gene expression, as well as posttranslationally, and that responsiveness to these hormonal effects is dependent on adipose depot and gender. (J. Clin. Invest. 1993. 92:2191-2198
Introduction
The regional distribution of fat in humans varies as a function of gender, hormonal status, and genetic predisposition ( 1) . With increasing fatness, men deposit more fat in intraabdominal fat depots than women, and women with upper body obesity generally deposit more intraabdominal fat than women with lower body obesity (2, 3) .
In both sexes, the size ofintraabdominal fat stores, independent of total body fatness, is highly correlated with metabolic abnormalities associated with obesity, including low HDL levels, hypertriglyceridemia, and glucose intolerance ( 1, 4, 5) .
Though heterogeneity in the metabolic activities of adipocytes from different fat depots has been extensively documented (6) , the cellular and molecular mechanisms regulating regional fat deposition are not fully understood. Recently, however, Amer and colleagues (7-9) have described differences among subcutaneous depots in the expression of mRNAs for a number of adipocyte proteins.
One important determinant of triglyceride storage in the adipocyte is the activity of the enzyme lipoprotein lipase (LPL)' ( 10 ) . LPL catalyzes the hydrolysis ofcirculating triglycerides to free fatty acids, which can then be reesterified and stored in the adipocyte. Regional variations in adipose tissue LPL activity have been demonstrated, and these differences closely parallel regional variations in fat cell size (1 [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] . We have previously shown that omental (OM) adipose tissue from women has smaller adipocytes with lower LPL activity than subcutaneous (SQ) depots, and that such regional differences are not apparent in men ( 11) . In both sexes, OM adipose tissue, compared with SQ abdominal adipose tissue, is more responsive to lipolytic effects of catecholamines, less sensitive to insulin's (Ins's) antilipolytic action, and has a higher density of glucocorticoid receptors (8, (14) (15) (16) ).
An important role for glucocorticoids in enhancing central fat accumulation is suggested by the fact that the hypercortisolemia of Cushing syndrome is associated with a marked increase in the size of intraabdominal fat stores ( 17) , and a specific increase in the activity ofLPL in abdominal SQ compared with thigh fat ( 18) .
The cellular and molecular mechanisms regulating LPL activity are not yet established, but transcriptional and posttranscriptional mechanisms (mRNA stability, translation, glycosylation, and activation) appear to operate in different situations ( 10) . Obesity-and meal-induced increases in LPL activity cannot be explained by variations in levels of LPL mRNA, and are apparently associated with increases in LPL-specific activity (19) (20) (21) .
Mechanisms of the hormonal regulation of LPL have been studied using cultures of intact adipose tissue fragments and isolated adipocytes. In cultured abdominal SQ human adipose tissue, in contrast to results in cultured isolated OM adipocytes (20, 22) , Ins increases LPL activity by increasing LPL synthesis (23) . Glucocorticoids added in the presence ofIns markedly increase LPL activity primarily by acting posttranslationally (23) .
The major purpose ofthe present experiments was to investigate whether changes in the level of LPL mRNA parallel Ins and dexamethasone stimulation of LPL synthesis in cultured human adipose tissue. Because OM adipose tissue is less sensitive to Ins ( 14) and has a higher concentration of glucocorticoid receptors (8), we hypothesized that LPL regulation by Ins and glucocorticoids would differ in this tissue. Adipose tissues from men and women were compared because regional variations in adipose tissue LPL activity are more prominent in women than men.
Methods
Organ culture of human adipose tissues. Human adipose tissue was obtained at surgery from SQ epigastric abdominal depots or the peripheral portion ofthe OM, as previously described ( 11 ) . Most patients ( 38 women and 18 men) were undergoing gastrointestinal surgery for morbid obesity. Samples were also taken from several women (n = 6) who had lost substantial weight as a result of obesity surgery, and were undergoing additional surgery. Because the pattern of hormonal response between depots did not differ between the formerly obese and obese patients, all data were pooled. Samples of adipose tissue were processed as previously described and minced adipose tissue fragments were placed in serum-free M 199 containing 25 mM Hepes, Earles salts, with or without varying concentrations of insulin (0-7 nM; Humulin; Eli Lilly, Indianapolis, IN), or dexamethasone (0-250 nM), alone or in combination. Cultures were maintained for 7-8 d, and the hormonesupplemented media were replenished every 2-3 d. Cultures were used on days 6-8, after being refed the previous day (23, 24) .
Measurement ofLPL activity. LPL activity in heparin eluates from adipose tissue fragments was measured as previously described ( 11 (24) . After homogenization in lysis buffer, incorporation of radioactivity into TCA-precipitable protein was measured, and volumes of homogenates representing equal TCA counts were used for immunoprecipitation of LPL as previously described (24), using a rabbit anti-human milk LPL antiserum ( 13) .
RNA extraction and Northern blotting. RNA was isolated from -I g of adipose tissue after homogenization in guanidinium isothiocyanate buffer, and phenol-chloroform extraction (25) . To prepare RNA from isolated fat cells, cultured adipose tissue was digested with collagenase (1 mg/ml) as previously described (26) , except that all buffers were supplemented with 100 nM phenylisopropyladenosine. The lack of degradation of the RNA and equal loading of total RNA per lane were verified by visualization of ribosomal RNA subunits with ethidium bromide. Northern transfer and hybridization with cDNAs to human LPL, gamma actin, and 28S ribosomal subunit were accomplished as previously described (24). After exposure of gels to x-ray film, autoradiographs were quantified by laser scanning densitometry (ultra scan XL; LKB Produkter, Bromma, Sweden).
Statistical analysis. All data are presented as means±SE. After log transformation ofthe data, individual means were compared by analysis ofvariance (ANOVA) with sex as a grouping variable, and repeated measures on hormone dose and depot using the program Systat. Individual means were compared by post hoc paired t tests (depot effects, dose effects) or independent t test (gender effects), when ANOVA indicated significant overall effects (P < 0.05) (27) .
Results
Patient characteristics. Patients were on average severely obese, as indicated by the average body mass index (BMI). The BMI and age of the men and women were comparable (Table  I ). In women, but not men, OM fat cells were significantly smaller than those from the SQ site (Table I) . Expression ofLPL mRNA in OM and SQ adipose tissues. To determine whether decreased LPL activity in OM adipose tissue of women ( 11) is associated with changes in levels of LPL mRNA, Northern analyses of RNA from OM and SQ adipose tissues was performed (Fig. 1) . Levels of LPL relative to actin were significantly lower in OM than SQ adipose tissue ofwomen (P < 0.05; Fig. 1 ). It was noted that for equal quantities of RNA loaded onto the gels, levels of actin mRNA were 16% lower (3, (Fig. 3 ). In agreement with previous results, Ins caused a dose-dependent increase in LPL activity, with an average of I0-fold over basal in abdominal SQ adipose tissue (23) (Fig. 3) (Fig. 4) . Levels of LPL mRNA in the absence and presence of Ins were significantly greater in SQ than OM adipose tissue (Table II) .
Dex effects on LPL activity and LPL mRNA levels in OM and SQ adipose tissues. Significant effects of Dex were obtained in OM adipose tissue ofmen and women (P < 0.01; Fig.  5 ). In OM, Dex produced a dose-dependent, approximately threefold stimulation of LPL activity that was maximal at a concentration of25 nM. At 25 nM Dex, LPL activity was significantly higher in OM than SQ adipose tissue (P < 0.01 in men and women). Although the ANOVA indicated no interactions involving gender, post hoc t tests failed to detect a significant Dex effect at any dose tested in SQ adipose tissue of men, in agreement with data on a larger number ofsubjects tested at 25 nM (see Fig. 2 ). In women, effects of Dex on SQ LPL activity were statistically significant at doses of 2 0.25 nM (P < 0.05). It is also noteworthy that a high dose of Dex (250 nM) resulted in lower LPL activity than 25 nM (P < 0.02) in the OM depot of men and women.
Paralleling depot differences in LPL activity, 2.5 and 25 nM Dex produced a three-to fourfold (OM) increase in LPL mRNA levels ( Fig. 6 and Table II ). In SQ adipose tissue, only 2.5 nM Dex increased LPL mRNA levels.
Dex effects in thepresence ofIns on LPL activity in OMand SQ adipose tissues. There were no significant effects of gender determined by ANOVA. The two depots responded differently when varying concentrations of Dex were added in the presence of a maximally stimulating dose of Ins (Fig. 7) . At (Table II) .
LPL mRNA in isolatedfat cells. To confirm that effects of Ins and Dex on LPL mRNA were expressed at the level of the fat cell, rather than only in other cells present in intact tissue fragments, RNA was extracted from fat cells isolated by collagenase digestion of cultured adipose tissue fragments. As shown in Fig. 8 (22, 29) . Further investigation is required to determine whether Ins would affect LPL in isolated abdominal adipocytes, or whether paracrine factors are also involved.
The present data also demonstrate that the ability of Ins to increase LPL activity and synthesis in cultured human adipose tissue is due to increases in steady-state levels of LPL mRNA.
This result is in agreement with data in isolated rat adipocytes showing that increases in LPL mRNA were due to a stabilization of the mRNA rather than an increase in transcription (30) . The mechanisms involved in human adipose tissue will require further investigation.
The decreased ability of Ins to stimulate LPL in OM adipose tissue is consistent with the insensitivity of this tissue to the antilipolytic effect of Ins ( 14) . Thus, the lower LPL in OM adipose tissue may be a general feature of an overall Ins resistance. The molecular mechanisms involved are not known, but the observed difference in Ins action on LPL gene expression in OM and SQ adipose tissue provides an interesting model for dissecting tissue-specific factors governing Ins responsiveness.
These data also confirm and extend our previous report that glucocorticoids are important regulators of human adipose tissue LPL (23) . Dex alone produced only small increments in LPL activity in the SQ adipose tissue of women. This effect was less apparent in the SQ adipose tissue of men. In marked contrast, OM adipose tissue of both men and women was highly responsive to stimulatory effects of Dex on LPL activity. Increases in LPL activity in adipose tissue cultured with Dex were largely explained by the ability of this hormone to increase levels of LPL mRNA. These data agree well with reports of higher numbers of glucocorticoid receptors in OM compared with SQ adipose tissues (32, 33).
Synergistic effects ofcombinations ofIns and Dex were also observed in both fat depots. Sensitivity to submaximal doses of Dex, in the presence of a maximal Ins concentration, was higher in the SQ depot of men and women. The increased sensitivity ofthe SQ adipose tissue to Dex in the presence ofIns may reflect the greatly increased responsiveness ofthis tissue to Ins, as no differential sensitivity to submaximal concentrations of Dex alone was apparent in the two tissues (Fig. 5 ).
Maximally induced levels of LPL activity and LPL mRNA (7 nM Ins plus 25 nM Dex) were greater in the SQ than OM depot of women, but were similar in men. The lower maximal expression of LPL activity in cultured OM adipose tissue of women is in good agreement with previous findings of lower LPL activity ( 11) and LPL mRNA levels (present results) observed in OM compared with SQ adipose tissue of women. Thus, differences in responsiveness to effects of Ins and glucocorticoids on LPL may play a role in controlling regional variations in LPL activity.
The lower activity of LPL activity in OM adipose tissue of women must be considered relative to the smaller size ofthe fat cells in this depot. The difference in activity persists whether the data are calculated on a per cell or per fat cell surface area basis ( 1 1, 16 ). Because recovery of RNA cannot be quantified, it is impossible to calculate LPL mRNA per cell, and it is difficult to determine whether observed changes in LPL mRNA levels fully account for observed differences in activity ( 11) .
Nevertheless, it is clear that changes in the relative abundance of LPL mRNA occur, indicating that specific changes in the expression of this gene occur both in vivo, as indicated by the results in fresh samples ofadipose tissue, and in vitro under the influence of specific hormones.
It is also difficult to determine whether the magnitude of the increases in LPL mRNA in the presence of specific hormones can account for the observed variations in heparin-releasable LPL activity. Ins increased the specific expression of LPL mRNA relative to total RNA an average oftwofold. However, the apparent yield of RNA was also increased by about twofold in the presence of Ins (our unpublished observation), so that the combination of specific and nonspecific increases in LPL mRNA appear to account for the increases in LPL activity. Dex did not affect apparent yield, and the specific increase in LPL mRNA relative to total RNA appears to account for the increase in LPL synthesis and activity. In the presence of Ins plus Dex, LPL mRNA levels were only two-to fourfold higher than in the presence of Ins alone. The magnitude of this increase in LPL mRNA is in good agreement with the maximum of 2-3-fold stimulations of LPL synthesis, but is insufficient to explain observed increases ( 5-1 0-fold) in LPL activity in the presence of maximal concentrations of Ins and Dex. Thus, changes in posttranslational LPL regulation, possibly variations in responsiveness to the ability ofDex to decrease the rate of LPL degradation (23), may also play an important role in depot differences in LPL.
To assess whether hormone-induced variations in LPL mRNA levels were due to changes at the level ofthe adipocyte, rather than other cells present in adipose tissue fragments, we isolated RNA from isolated fat cells prepared from cultured adipose tissue. Similar increases in LPL mRNA were seen in RNA isolated from fat cells and tissue, showing that LPL expression in the mature adipocytes is affected. Levels of LPL mRNA in the stromal vascular (non-fat cell) fraction are only a small percentage of levels in adipocytes in subcutaneous tissue (7) . We have also recently reported that LPL expression is very low in the non-fat cell fraction of cultured OM and SQ adipose tissues (< 5% of fat cell expression) (34) . Thus, the changes in adipose tissue LPL mRNA levels observed during culture of adipose tissue are not due to hormone-induced differentiation of preadipocytes that could exist within the tissue.
Dex increased LPL activity and mRNA in OM adipose tissue (and to a lesser extent in SQ adipose tissue of women). This result is opposite ofa report by Ong et al. (35) , who found that Dex actually decreased LPL mRNA levels and activity in rat adipocytes, and that there was no synergism between effects of Ins and Dex. The explanation for this may lie in species differences or paracrine interactions within adipose tissue.
Regional differences in the expression of mRNAs encoding LPL (7), beta adrenergic receptors (9) , and glucocorticoid receptors (8) have also been demonstrated between human subcutaneous abdominal and gluteal adipose tissues. Thus, it is clear that adipose tissue is a heterogeneous organ. Moreover, the data presented here show that such depot differences persist after long-term culture, and may be due to variations in responsiveness to specific hormonal effects. Therefore, regional differences in adipocyte metabolism are not likely to be simply secondary to depot differences in the in vivo milieu (blood flow, innervation). In addition, the lower LPL mRNA expression in OM adipose tissue of women is apparently specific, as it is apparent relative to total RNA, and the expression of at least one other specific mRNA, for the glucocorticoid receptor, is increased (32).
A recent report suggested that the extent of trimming of LPL oligosaccharides differs between human OM and SQ adipose tissues (36) . Since no activity data were given, and the sex of the patients was not specified, the importance of these changes is unclear. It is possible that differential responses to hormonal effects on LPL activity are in part due to altered processing of LPL.
The present data suggest an important role for glucocorticoids in the regulation of LPL in human adipose tissue. The observation by Rebuffe-Scrive et al. ( 18) , that LPL activity is increased in the abdominal SQ adipose tissue (but not thigh fat) ofpatients with Cushing syndrome, supports the relevance of these findings in organ culture to the in vivo situation. No data are currently available on the expression of LPL in the OM depot of Cushing patients.
Some caution must be used in extrapolating the present findings using adipose tissue from severely obese subjects to adipose tissue from lean or more moderately obese subjects. Differences in the replicative capacity and mitogenic protein production of adipocyte precursors from severely obese compared with lean subjects have been reported (37) . However, because the pattern ofdepot differences in LPL activity, fat cell size, and other metabolic variables are similar in severely obese subjects and moderately obese or lean subjects ( 1 1, 12, 16, 18, 28, 38) , it is unlikely that the present findings are unique to very obese patients. Furthermore, similar results were obtained in formerly obese subjects (n = 6; data not shown) that were included in the present study so that the depot differences observed here are not likely to be simply secondary to the obesity.
In summary, OM and SQ adipose tissues from obese subjects differ in sensitivity and responsiveness to effects ofIns and glucocorticoids on LPL gene expression, LPL synthesis, and LPL activity. These differences could arise by the depot-specific expression of "tissue-specific" regulatory factors, in a manner analogous to differences in LPL regulation in adipose tissue and muscle (10) . Regardless of the molecular mechanisms involved, the present data suggest that regional variations in the hormonal regulation of LPL among adipose tissues contribute to in vivo variations in enzyme activity. Enhanced responsiveness to glucocorticoid effects in OM adipose tissue may contribute to increased visceral fat deposition in upper body obese women who show increased cortisol turnover (39) , and in patients with Cushing syndrome. Relative resistance to the synergistic effects of Ins and glucocorticoids on OM compared with the SQ adipose tissue of women may underlie the decreased expression of £PL activity and mRNA in this depot. These differences in the hormonal regulation of LPL may play a role in modulating regional deposition of fat in humans.
